CRP gene variation and risk of community-acquired pneumonia

Respirology

Volumn 15, Issue 1, 2010, Pages 160-164

  Mukamal, Kenneth J ^a   Pai, Jennifer K ^b,c   O'Meara, Ellen S ^b   Tracy, Russell P ^g   Psaty, Bruce M ^f   Kuller, Lewis H ^g   Newman, Anne B ^h   Yende, Sachin ⁱ   Curhan, Gary C ^b,d,e   Siscovick, David S ^f   Rimm, Eric B ^b,c,d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Department of Epidemiology ^*

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d CHANNING LABORATORY   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g University of Vermont   (Canada)

^h UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

C reactive protein; Cohort study; Epidemiology; Pneumonia; Single nucleotide polymorphism

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; FEMALE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; PNEUMONIA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 74049115404     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01661.x     Document Type: Article

References (34)

1. Westhuyzen J, Healy H. Review: biology and relevance of C-reactive protein in cardiovascular and renal disease. Ann. Clin. Lab. Sci. 2000 30 : 133 143.
2. Horowitz J, Volanakis JE, Briles DE. Blood clearance of Streptococcus pneumoniae by C-reactive protein. J. Immunol. 1987 138 (8 2598 2603.
3. Szalai AJ, Briles DE, Volanakis JE. Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae. Infect. Immun. 1996 64 (11 4850 4853.
4. Boeken U, Feindt P, Zimmermann N et al. Increased preoperative C-reactive protein (CRP)-values without signs of an infection and complicated course after cardiopulmonary bypass (CPB)-operations. Eur. J. Cardiothorac. Surg. 1998 13 : 541 545.
5. Fransen EJ, Maessen JG, Elenbaas TW et al. Enhanced preoperative C-reactive protein plasma levels as a risk factor for postoperative infections after cardiac surgery. Ann. Thorac. Surg. 1999 67 : 134 138.
6. Matzke S, Biancari F, Ihlberg L et al. Increased preoperative C-reactive protein level as a prognostic factor for postoperative amputation after femoropopliteal bypass surgery for CLI. Ann. Chir. Gynaecol. 2001 90 : 19 22.
7. Povoa P, Almeida E, Moreira P et al. C-reactive protein as an indicator of sepsis. Intensive. Care. Med. 1998 24 : 1052 1056.
8. Casas JP, Shah T, Cooper J et al. Insight into the nature of the CRP-coronary event association using mendelian randomization. Int. J. Epidemiol. 2006 35 : 922 931.
9. Roy S, Hill AV, Knox K et al. Research pointers: association of common genetic variant with susceptibility to invasive pneumococcal disease. BMJ 2002 324 (7350 1369.
10. Hawn TR, Verbon A, Lettinga KD et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J. Exp. Med. 2003 198 (10 1563 1572.
11. Hawn TR, Verbon A, Janer M et al. Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. Proc. Natl. Acad. Sci. USA 2005 102 (7 2487 2489.
12. Kiechl S, Lorenz E, Reindl M et al. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 2002 347 (3 185 192.
13. Schroder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet. Infect. Dis. 2005 5 (3 156 164.
14. Van der Graaf CA, Netea MG, Morre SA et al. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur. Cytokine. Netw. 2006 17 : 29 34.
15. Garred P, Madsen HO, Halberg P et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis. Rheum. 1999 42 (10 2145 2152.
16. Roy S, Knox K, Segal S et al. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 2002 359 (9317 1569 1573.
17. Gomi K, Tokue Y, Kobayashi T et al. Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest 2004 126 : 95 9.
18. Lange LA, Carlson CS, Hindorff LA et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006 296 : 2703 2711.
19. Carlson CS, Aldred SF, Lee PK et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am. J. Hum. Genet. 2005 77 : 64 77.
20. Fried LP, Borhani NO, Enright P et al. The Cardiovascular Health Study: design and rationale. Ann. Epidemiol. 1991 1 : 263 276.
21. Kraft P, Cox DG, Paynter RA et al. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet. Epidemiol. 2005 28 : 261 272.
22. Pankow JS, Folsom AR, Cushman M et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 2001 154 (3 681 689.
23. O'Meara ES, White M, Siscovick DS et al. Hospitalization for pneumonia in the Cardiovascular Health Study: incidence, mortality, and influence on longer-term survival. J. Am. Geriatr. Soc. 2005 53 (7 1108 1116.
24. Psaty BM, Kuller LH, Bild D et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann. Epidemiol. 1995 5 (4 270 277.
25. Ng'andu NH. An empirical comparison of statistical tests for assessing the proportional hazards assumption of Cox's model. Stat. Med. 1997 16 : 611 626.
26. Baik I, Curhan GC, Rimm EB et al. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch. Intern. Med. 2000 160 (20 3082 3088.
27. Pai JK, Mukamal KJ, Rexrode KM et al. C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies. PloS ONE 2008 3 (1 e1395.
28. Szalai AJ, McCrory MA, Cooper GS et al. Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Genes. Immun. 2002 3 : 14 19.
29. Schultz DR, Arnold PI. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin. Arthritis. Rheum. 1990 20 (3 129 147.
30. Ramage L, Proudfoot L, Guy K. Expression of C-reactive protein in human lung epithelial cells and upregulation by cytokines and carbon particles. Inhal. Toxicol. 2004 16 (9 607 613.
31. Ramage L, Guy K. Expression of C-reactive protein and heat-shock protein-70 in the lung epithelial cell line A549, in response to PM10 exposure. Inhal. Toxicol. 2004 16 (6-7 447 452.
32. Dong Q, Wright JR. Expression of C-reactive protein by alveolar macrophages. J. Immunol. 1996 156 (12 4815 4820.
33. Bont J, Hak E, Hoes AW et al. A prediction rule for elderly primary-care patients with lower respiratory tract infections. Eur. Respir. J. 2007 29 (5 969 975.
34. van der Eerden MM, Vlaspolder F, de Graaff CS et al. Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 2005 24 (4 241 249.